Spencer Pharmaceutical Inc. (SPPH)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 22, 2026
Market Cap271.00
Revenue (ttm)n/a
Net Income (ttm)-943.20K
Shares Out271.27M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,600
Average Volume30,617
Open0.0000
Previous Closen/a
Day's Range0.0000 - 0.0000
52-Week Range0.0000 - 0.0000
Beta37.44
RSI41.01
Earnings Daten/a

About Spencer Pharmaceutical

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol SPPH
Full Company Profile

Financial Performance

Financial Statements